Screener / SEC EDGAR /CIK 0001032220 /10-K filed Nov 20, 2025, compared with Nov 21, 2024 /Numbers from the XBRL of the 10-Ks
NYSE Industrials · Business Services

Maximus, Inc. MMS

Compare with peers Embed
FY2025 at a glance

Sales up 2.4%, free cash flow down to $366.2M

XBRL, from each 10-K
RevenueStatements
$5.4B from $5.3B in FY2024
FY2016FY2025
Net incomeStatements
$319.0M from $306.9M in FY2024
FY2016FY2025
Free cash flowStatements
$366.2M from $401.1M in FY2024
FY2016FY2025
EPS (diluted)Statements
$5.51 from $4.99 in FY2024
FY2016FY2025
Operating marginStatements
9.7% from 9.2% in FY2024
FY2016FY2025
Total debtStatements
$1.3B from $1.1B in FY2024
FY2016FY2025

The latest figures

Price and key numbers

From EDGAR
All key numbers (45)
EPS (ttm)
6.76
Sales (ttm)
5.2B
Net income (ttm)
370.9M
Sales growth
+2.4%
EPS growth
+10.4%
Sales Q/Q
-5.1%
Free cash flow
433.2M
Gross margin
25.6%
Oper. margin
11.0%
Net margin
7.1%
FCF margin
8.3%
ROA
8.5%
R&D / sales
-
Dividend
1.20
Debt/Eq
0.94
Curr. ratio
2.42
Cash
57.0M
Op. cash flow (ttm)
469.5M
EBITDA
570.0M
EBITDA margin
10.5%
Net debt
1.6B
Quick ratio
2.42
Interest cover
6.28
ROIC
11.2%
Payout ratio
21.8%
FCF after stock pay
325.0M
Debt / FCF (years)
4.47
Goodwill / assets
43.8%
Oper. margin low 5y
6.0%
Tax rate
28.3%
Stock pay / sales
0.8%
Shares out.
52.4M
Shares Y/Y
-5.8%
Book / share
33.24
Cash / share
1.09
Sales / share
100.24
Asset turnover
1.20
Days sales out.
60
Sales 3Y CAGR
+5.5%
Sales 5Y CAGR
+9.4%
EPS 3Y CAGR
+18.8%
EPS 5Y CAGR
+10.2%
Employees
37,200
Sales / employee
141K

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Revenue and net income, FY2016 to FY2025

Each fiscal year from its own 10-K · XBRL

Revenue 5.4B +9.5% a year Net income 319.0M +6.7% a year
FY2016 revenue 2.4B · Revenues, 0001032220-18-000090 FY2016 net income 178.4M · NetIncomeLoss, 0001032220-18-000090 2.4B FY2016 FY2017 revenue 2.5B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001032220-19-000105 FY2017 net income 209.4M · NetIncomeLoss, 0001032220-19-000105 2.5B FY2017 FY2018 revenue 2.4B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001032220-20-000102 FY2018 net income 220.8M · NetIncomeLoss, 0001032220-20-000102 2.4B FY2018 FY2019 revenue 2.9B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-21-023790 FY2019 net income 240.8M · NetIncomeLoss, 0001628280-21-023790 2.9B FY2019 FY2020 revenue 3.5B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001032220-22-000074 FY2020 net income 214.5M · NetIncomeLoss, 0001032220-22-000074 3.5B FY2020 FY2021 revenue 4.3B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001032220-23-000096 FY2021 net income 291.2M · NetIncomeLoss, 0001032220-23-000096 4.3B FY2021 FY2022 revenue 4.6B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001032220-24-000094 FY2022 net income 203.8M · NetIncomeLoss, 0001032220-24-000094 4.6B FY2022 FY2023 revenue 4.9B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001032220-25-000053 FY2023 net income 161.8M · NetIncomeLoss, 0001032220-25-000053 4.9B FY2023 FY2024 revenue 5.3B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001032220-25-000053 FY2024 net income 306.9M · NetIncomeLoss, 0001032220-25-000053 5.3B FY2024 FY2025 revenue 5.4B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001032220-25-000053 FY2025 net income 319.0M · NetIncomeLoss, 0001032220-25-000053 5.4B FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2016 to FY2025 (9 years).

From the same starting line, FY2016 to FY2025

Revenue, net income and free cash flow, each set to 100 in FY2016. What happened, from the 10-Ks. Not a forecast.

FY2016 = 100
100 150 200 Revenue: $2.4B in FY2016, $5.4B in FY2025 REVENUE $5.4B · 2.3x Net income: $178.4M in FY2016, $319.0M in FY2025 NET INCOME $319.0M · 1.8x FY2016 = 100FY2021FY2025
Revenue 2.3x $2.4B to $5.4B
Net income 1.8x $178.4M to $319.0M

Growth per share, FY2015 to FY2025

Earnings, book value and free cash flow for each diluted share · 10-K XBRL, every year linked to its filing

Average yearly growth
Earnings per share +8.9% a year FY2015 $2.35 to FY2025 $5.51, 10 years
Book value per share +12.2% a year FY2015 $9.10 to FY2025 $28.90, 10 years
Free cash flow per share +5.3% a year FY2018 $4.40 to FY2025 $6.32, 7 years
100 200 300 EPS: $2.35 in FY2015, $5.51 in FY2025 EPS $5.51 · 2.3x Book value / share: $9.10 in FY2015, $28.90 in FY2025 BOOK VALUE / SHARE $28.90 · 3.2x FY2015 = 100FY2020FY2025

Each line is set to 100 in FY2015, so a line at 200 has doubled. What was filed, not a forecast. A line is left out when it is not above zero in every year.

Fiscal year toEPS (diluted)Book value / shareFree cash flow / share
Sep 30, 2025 $5.51$28.90$6.32
Sep 30, 2024 $4.99$29.97$6.52
Sep 30, 2023 $2.63$27.14$3.64
Sep 30, 2022 $3.29$25.00$3.77
Sep 30, 2021 $4.67$23.74$7.71
Sep 30, 2020 $3.39$19.61$3.22
Sep 30, 2019 $3.72$19.25$4.47
Sep 30, 2018 $3.35$16.44$4.40
Sep 30, 2017 $3.17$14.23-
Sep 30, 2016 $2.69$11.31-
Sep 30, 2015 $2.35$9.10$1.59

Per share means per diluted weighted-average share of the same fiscal year (the count under diluted EPS, put on today's share count after a split). Book value is shareholders' equity at the year end, including any preferred stock; free cash flow is operating cash flow less capital spending. Each tile's rate is the steady yearly growth from the first to the last year it names: the window starts at the oldest year, up to ten years back, with a value above zero.

What the balance sheet holds, per share

Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used

Net current asset value, FY2025, in dollars
  • + Current assets $1.3B
  • − All liabilities $2.4B
  • = Net current asset value -$1.1B
Per share, year by year
Tangible book value, FY2025, in dollars
  • + Shareholders' equity $1.7B
  • − Goodwill $1.8B
  • − Other intangible assets $538.3M
  • = Tangible book value -$646.3M
Per share, year by year

Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.

MMS against Industrials peers

Among the 258 companies, the better end on the right. The band holds the middle half; the line is the median.

Ten years, side by side
Sales growth
+0.7%+11.4%
+2.4%168th of 251 · median +5.7%
Net margin
3.8%13.8%
7.1%142nd of 252 · median 8.2%
Return on equity
9.4%27.1%
21.3%84th of 243 · median 15.1%
Free cash flow margin
4.9%15.3%
8.3%137th of 235 · median 9.6%
Debt / equity (less is better)
1.170.38
0.94147th of 224 · median 0.64
MMS and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthFYGross marginttmNet marginttmROEttmFCF marginttmDebt / equitylatest
MMS Maximus, Inc.$5.2B +2.4%25.6%7.1%21.3%8.3%0.94
RHI Robert Half Inc.$5.3B -7.2%37.3%2.3%10.1%3.9%-
NVT nVent Electric plc$5.3B +29.5%36.6%12.8%16.5%12.1%0.53
LSTR Landstar System Inc$5.3B -1.6%-3.0%19.3%3.0%0.00
SNA Snap-on$5.3B +0.9%-19.2%16.6%-0.20
ADT ADT Inc.$5.2B +4.7%-11.9%17.0%37.0%2.16
All 258 companies in the group

Where each dollar goes

Revenue through the costs to the net profit, from the 10-K income statement and revenue by product

From $4.3B of sales to $291.2M of profit FY2021

  • Program Operations $2.8B
  • Clinical Services $699.4M
  • Employment & Other $463.7M
  • Technology Solutions $335.5M
Revenue to Gross profit: $947.0MRevenue to Cost of revenue: $3.3BGross profit to Operating profit: $408.5MGross profit to Operating expenses: $538.4MOperating profit to Net profit: $291.2MOperating profit to Tax & other: $117.3M Revenue: $4.3B REVENUE $4.3B +23% Y/Y Gross profit: $947.0M · 22% margin GROSS PROFIT $947.0M 22% margin · +33% Y/Y Cost of revenue: $3.3B · 78% of revenue COST OF REVENUE $3.3B 78% of revenue Operating profit: $408.5M · 10% margin OPERATING PROFIT $408.5M 10% margin · +42% Y/Y Operating expenses: $538.4M · 13% of revenue OPERATING EXPENSES $538.4M 13% of revenue Net profit: $291.2M · 7% margin NET PROFIT $291.2M 7% margin · +36% Y/Y Tax & other: $117.3M · 3% of revenue TAX & OTHER $117.3M 3% of revenue

From $4.6B of sales to $203.8M of profit FY2022

  • Program Operations $2.5B
  • Clinical Services $1.2B
  • Employment & Other $551.8M
  • Technology Solutions $400.6M
Revenue to Gross profit: $939.8MRevenue to Cost of revenue: $3.7BGross profit to Operating profit: $325.9MGross profit to Operating expenses: $613.9MOperating profit to Net profit: $203.8MOperating profit to Tax & other: $122.1M Revenue: $4.6B REVENUE $4.6B +9% Y/Y Gross profit: $939.8M · 20% margin GROSS PROFIT $939.8M 20% margin · −1% Y/Y Cost of revenue: $3.7B · 80% of revenue COST OF REVENUE $3.7B 80% of revenue Operating profit: $325.9M · 7% margin OPERATING PROFIT $325.9M 7% margin · −20% Y/Y Operating expenses: $613.9M · 13% of revenue OPERATING EXPENSES $613.9M 13% of revenue Net profit: $203.8M · 4% margin NET PROFIT $203.8M 4% margin · −30% Y/Y Tax & other: $122.1M · 3% of revenue TAX & OTHER $122.1M 3% of revenue

From $4.9B of sales to $161.8M of profit FY2023

  • Program Operations $2.5B
  • Clinical Services $1.5B
  • Employment & Other $521.0M
  • Technology Solutions $397.0M
Revenue to Gross profit: $1.0BRevenue to Cost of revenue: $3.9BGross profit to Operating profit: $294.8MGross profit to Operating expenses: $733.8MOperating profit to Net profit: $161.8MOperating profit to Tax & other: $133.0M Revenue: $4.9B REVENUE $4.9B +6% Y/Y Gross profit: $1.0B · 21% margin GROSS PROFIT $1.0B 21% margin · +9% Y/Y Cost of revenue: $3.9B · 79% of revenue COST OF REVENUE $3.9B 79% of revenue Operating profit: $294.8M · 6% margin OPERATING PROFIT $294.8M 6% margin · −10% Y/Y Operating expenses: $733.8M · 15% of revenue OPERATING EXPENSES $733.8M 15% of revenue Net profit: $161.8M · 3% margin NET PROFIT $161.8M 3% margin · −21% Y/Y Tax & other: $133.0M · 3% of revenue TAX & OTHER $133.0M 3% of revenue

From $5.3B of sales to $306.9M of profit FY2024

  • Program Operations $2.6B
  • Clinical Services $1.9B
  • Employment & Other $469.3M
  • Technology Solutions $375.1M
Revenue to Gross profit: $1.3BRevenue to Cost of revenue: $4.1BGross profit to Operating profit: $488.5MGross profit to Operating expenses: $763.2MOperating profit to Net profit: $306.9MOperating profit to Tax & other: $181.6M Revenue: $5.3B REVENUE $5.3B +8% Y/Y Gross profit: $1.3B · 24% margin GROSS PROFIT $1.3B 24% margin · +22% Y/Y Cost of revenue: $4.1B · 76% of revenue COST OF REVENUE $4.1B 76% of revenue Operating profit: $488.5M · 9% margin OPERATING PROFIT $488.5M 9% margin · +66% Y/Y Operating expenses: $763.2M · 14% of revenue OPERATING EXPENSES $763.2M 14% of revenue Net profit: $306.9M · 6% margin NET PROFIT $306.9M 6% margin · +90% Y/Y Tax & other: $181.6M · 3% of revenue TAX & OTHER $181.6M 3% of revenue

From $5.4B of sales to $319.0M of profit FY2025

  • Program Operations $2.7B
  • Clinical Services $2.1B
  • Employment & Other $354.8M
  • Technology Solutions $324.7M
Revenue to Gross profit: $1.3BRevenue to Cost of revenue: $4.1BGross profit to Operating profit: $528.3MGross profit to Operating expenses: $805.2MOperating profit to Net profit: $319.0MOperating profit to Tax & other: $209.3M Revenue: $5.4B REVENUE $5.4B +2% Y/Y Gross profit: $1.3B · 25% margin GROSS PROFIT $1.3B 25% margin · +7% Y/Y Cost of revenue: $4.1B · 75% of revenue COST OF REVENUE $4.1B 75% of revenue Operating profit: $528.3M · 10% margin OPERATING PROFIT $528.3M 10% margin · +8% Y/Y Operating expenses: $805.2M · 15% of revenue OPERATING EXPENSES $805.2M 15% of revenue Net profit: $319.0M · 6% margin NET PROFIT $319.0M 6% margin · +4% Y/Y Tax & other: $209.3M · 4% of revenue TAX & OTHER $209.3M 4% of revenue

Where each $100 of sales went

FY2021
FY2022
FY2023
FY2024
FY2025
  • Cost of revenue
  • Sales, admin & other
  • Tax & other
  • Net profit

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement

Where the return on equity comes from

DuPont: net margin × asset turnover × leverage, FY2025 against FY2020 · 10-K XBRL, year-end balances

Return on equity 19.1% FY2020: 17.3% net income ÷ equity
Net margin 5.9% FY2020: 6.2% profit per $ of sales: 319.0M ÷ 5.4B
Asset turnover 1.33× FY2020: 1.71× sales per $ of assets: 5.4B ÷ 4.1B
Leverage 2.43× FY2020: 1.63× assets per $ of equity: 4.1B ÷ 1.7B

The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.

Profitability

  • Net margin below the peer median
    7.1% vs 8.2%
  • Gross margin up over 5 years
    20.5% → 24.6%
  • Return on equity above 15%
    21.3%
  • A profit in every one of 10 years
Net margin, FY2016 to FY2025: 7.4% to 5.9%

Balance sheet

  • Interest covered more than 5 times
    Operating income is 6.3× interest expense
  • Debt smaller than equity
    Debt / equity 0.94 on the latest balance sheet (peer median 0.64)
  • Current assets cover current liabilities
    Current ratio 2.42
  • Net debt over 3 years of free cash flow
    $1.6B net debt, 3.6 years
Debt / equity at each year end, FY2016 to FY2025: 0.22 to 0.80

Cash and shareholders

  • Free cash flow positive in every one of 8 years
    $366.2M last year
  • Share count down over 5 years
    −8.5%
  • Dividend per share up over 5 years
    $1.12 → $1.20
  • Cash from operations above net income
    $429.4M vs $319.0M
Free cash flow, FY2016 to FY2025: 290.3M to 366.2M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

$855.7M of principal due, schedule of Jun 30, 2026

Debt

Repayment schedule

From the balance sheet in the latest 10-K or 10-Q (XBRL). When each part falls due, year by year, and the debt note's own lines are on the Debt tab.

Contracted revenue and deferred revenue

Backlog (remaining performance obligations) and cash received in advance, by balance sheet date · XBRL

Remaining performance obligations

Signed, not yet recognized $230.0M revenue under contracts the company has not delivered yet, Jun 30, 2026 · -30.3% on a year earlier

Contract liabilities

Paid in advance $72.5M cash received before delivery, not yet recognized as revenue, Jun 30, 2026 · -39.2% on a year earlier

Both are balance-sheet-date values from the 10-K and 10-Qs. Backlog is what is under contract, not a forecast: contracts can be cancelled or change in size, and a company counts them in its own way. Hover a number for its XBRL line; click it to open the filing.

Income statement, balance sheet and cash flow

Statements · XBRL, each 10-K and 10-Q

From EDGAR

MMS's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 10. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Revenue5.4B
FY2016: 2.4BFY2017: 2.5BFY2018: 2.4BFY2019: 2.9BFY2020: 3.5BFY2021: 4.3BFY2022: 4.6BFY2023: 4.9BFY2024: 5.3BFY2025: 5.4B FY2017FY2019FY2021FY2023FY2025
Net income319.0M
FY2016: 178.4MFY2017: 209.4MFY2018: 220.8MFY2019: 240.8MFY2020: 214.5MFY2021: 291.2MFY2022: 203.8MFY2023: 161.8MFY2024: 306.9MFY2025: 319.0M FY2017FY2019FY2021FY2023FY2025
Free cash flow366.2M
FY2016: -FY2017: -FY2018: 290.3MFY2019: 289.9MFY2020: 203.9MFY2021: 480.8MFY2022: 233.7MFY2023: 223.6MFY2024: 401.1MFY2025: 366.2M FY2017FY2019FY2021FY2023FY2025
Free cash flow after stock pay325.0M
FY2016: -FY2017: -FY2018: 270.0MFY2019: 269.1MFY2020: 180.2MFY2021: 452.2MFY2022: 203.2MFY2023: 194.1MFY2024: 365.7MFY2025: 325.0M FY2017FY2019FY2021FY2023FY2025
EPS (diluted)5.51
FY2016: 2.69FY2017: 3.17FY2018: 3.35FY2019: 3.72FY2020: 3.39FY2021: 4.67FY2022: 3.29FY2023: 2.63FY2024: 4.99FY2025: 5.51 FY2017FY2019FY2021FY2023FY2025
Dividend per share1.20
FY2016: 0.18FY2017: 0.18FY2018: 0.18FY2019: 1.00FY2020: 1.12FY2021: 1.12FY2022: 1.12FY2023: 1.12FY2024: 1.20FY2025: 1.20 FY2017FY2019FY2021FY2023FY2025
Diluted shares57.9M
FY2016: 66.2MFY2017: 66.1MFY2018: 65.9MFY2019: 64.8MFY2020: 63.3MFY2021: 62.4MFY2022: 62.0MFY2023: 61.5MFY2024: 61.5MFY2025: 57.9M FY2017FY2019FY2021FY2023FY2025

Revenue by business segment

year to Sep 30, 2025
RevenueSharevs year before
U.S.Federal Services 3.1B56.5% +12.1%
US Services 1.8B32.5% -7.7%
Outside the United States 599.9M11.0% -8.7%

10-K 0001032220-25-000053, segment and revenue notes (XBRL).

Revenue by product or service

year to Sep 30, 2025
RevenueSharevs year before
Program Operations 2.7B48.8% +3.1%
Clinical Services 2.1B38.7% +11.1%
Employment & Other 354.8M6.5% -24.4%
Technology Solutions 324.7M6.0% -13.4%

10-K 0001032220-25-000053, segment and revenue notes (XBRL).

Revenue by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
U.S.Federal Services1.9B2.3B2.4B2.7B3.1B
US Services1.7B1.6B1.8B1.9B1.8B
Outside the United States699.1M763.7M689.1M657.1M599.9M
Sum of segments4.3B4.6B4.9B5.3B5.4B

Operating income by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Outside the United States20.1M-15.2M-9.1M7.7M-
U.S.Federal Services189.1M234.9M249.7M333.6M-
US Services254.4M182.1M182.6M247.0M-

Revenue and operating income by business segment, as each 10-K reports them in its segment note (XBRL). Each year comes from the newest 10-K that reports it, so a year the company later recast shows the recast number; click a number to open that 10-K. Rows without a number were not reported as a separate segment that year. "Corporate and other" and "All other" are the 10-K's own lines for what is outside the segments.

Income statement

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue2.4B2.5B2.4B2.9B3.5B4.3B4.6B4.9B5.3B5.4B
Cost of revenue1.8B1.8B1.8B2.2B2.8B3.3B3.7B3.9B4.1B4.1B
Gross profit562.2M611.9M594.4M671.2M711.0M947.0M939.8M1.0B1.3B1.3B
SG&A269.1M284.6M285.2M321.0M387.1M494.1M534.5M639.2M671.6M713.1M
Operating income286.6M313.5M295.5M317.1M288.3M408.5M325.9M294.8M488.5M528.3M
Interest expense4.1M2.2M1.0M3.0M2.1M14.5M46.0M84.1M82.4M84.1M
Pretax income286.0M314.2M299.2M317.3M287.1M383.7M277.1M210.3M406.5M444.8M
Income tax105.8M102.1M78.4M76.8M72.6M92.5M73.3M48.5M99.6M125.8M
Net income178.4M209.4M220.8M240.8M214.5M291.2M203.8M161.8M306.9M319.0M
EPS (diluted)2.693.173.353.723.394.673.292.634.995.51
Diluted shares66.2M66.1M65.9M64.8M63.3M62.4M62.0M61.5M61.5M57.9M
Depreciation & amortization58.4M55.8M51.9M52.4M64.5M46.4M42.3M54.7M34.0M41.7M
EBITDA345.0M369.3M347.4M369.5M352.8M454.9M368.2M349.5M522.5M570.0M
Gross margin23.4%25.0%24.8%23.2%20.5%22.3%20.3%21.0%23.6%24.6%
Operating margin11.9%12.8%12.4%11.0%8.3%9.6%7.0%6.0%9.2%9.7%
Net margin7.4%8.5%9.2%8.3%6.2%6.8%4.4%3.3%5.8%5.9%
Revenue growth+14.5%+2.0%-2.4%+20.7%+19.9%+22.9%+8.9%+5.9%+8.2%+2.4%
EPS growth+14.5%+17.8%+5.7%+11.0%-8.9%+37.8%-29.6%-20.1%+89.7%+10.4%

Stock-based pay and leases

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)18.8M21.4M20.2M20.8M23.7M28.6M30.5M29.5M35.3M41.2M
Stock-based pay / revenue0.8%0.9%0.8%0.7%0.7%0.7%0.7%0.6%0.7%0.8%
Operating lease cost----102.8M111.2M90.4M76.6M69.1M56.1M
Operating lease cash paid----109.4M96.9M86.5M77.6M75.3M64.5M
Right-of-use assets---206.3M177.2M179.3M132.9M163.9M133.6M100.5M
Operating lease liabilities---214.5M184.8M197.8M150.2M179.2M144.9M109.9M

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Sources

Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.

Also

Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MMS/export.csv") into a cell.

Next:Peers in numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.